| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 08/28/2003 | US20030162787 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade |
| 08/28/2003 | US20030162778 Carbocyclic side chain containing metalloprotease inhibitors |
| 08/28/2003 | US20030162776 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
| 08/28/2003 | US20030162772 For example, N-(2-(3-((1-(3,4-dichlorobenzylpiperidinyl) aminohydroxypropoxy)phenyl)acetamide; use as modulators of chemokine receptor activity, and may be used in treatment of autoimmune, inflammatory, proliferative diseases |
| 08/28/2003 | US20030162198 Medical diagnosis; complexing to Dna; calibration |
| 08/28/2003 | CA2475864A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation, as well as novel processes for preparing atorvastatin hemi-calcium forms i, viii and ix |
| 08/28/2003 | CA2475123A1 Desolvating solvates of atorvastatin hemi-calcium |
| 08/27/2003 | EP1338588A1 Method of resolving optical isomers of amino acid derivative |
| 08/27/2003 | EP1338336A1 Catalysts comprising n-substituted cyclic imides and processes for preparing organic compounds with the catalysts |
| 08/27/2003 | EP1337532A2 Compound for chelating a metal, radiopharmaceutical, manufacturing process therefor, and diagnostic kit |
| 08/27/2003 | EP1337511A1 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 08/27/2003 | EP1257360A4 Chiral ferrocene phosphines and their use in asymmetric catalytic reactions |
| 08/27/2003 | EP1165547B1 Substituted benzoylpyrazoles as herbicides |
| 08/27/2003 | EP1073672B1 Antipicornaviral compounds, their preparation and use |
| 08/27/2003 | EP0874809B1 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
| 08/27/2003 | EP0862552B1 Succinimide and maleimide cytokine inhibitors |
| 08/27/2003 | EP0802182B1 PROCESS FOR PRODUCING N-(D-alpha-METHYL-beta-MERCAPTOPROPIONYL)-L-PROLINE AND INTERMEDIATES THEREOF |
| 08/27/2003 | CN1439010A Pyrrolo [2,3-d] pyrimidine compounds as immunosuppressive agents |
| 08/27/2003 | CN1439006A Novel compounds possessing antibacterial, antifungal or antitumor activity |
| 08/27/2003 | CN1439005A Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/27/2003 | CN1438999A Serine protease inhibitors |
| 08/27/2003 | CN1438991A Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 08/27/2003 | CN1119346C Benzothiadiaxoles and derivatives |
| 08/27/2003 | CN1119340C Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 08/27/2003 | CN1119147C Kappa-opiate agonists for inflammatory bowel disorders |
| 08/26/2003 | US6610889 Using organometallic complex catalyst |
| 08/26/2003 | US6610850 Contrast media for angiography |
| 08/26/2003 | US6610731 Antiinflammatory |
| 08/26/2003 | US6610730 Viricides; protease inbhibitor |
| 08/26/2003 | US6610719 Use of prostaglandin (PGE2) receptor a (EP4) selective agonists for the treatment of acute and chronic renal failure |
| 08/26/2003 | US6610710 Inflammatory bowel diseases, diabetes, tumor proliferation and tumor metastasis. |
| 08/26/2003 | US6610708 Cyclic amino compounds |
| 08/26/2003 | US6610707 Heterocyclic compounds as inhibitors of rotomase enzymes |
| 08/26/2003 | US6610705 Process for the preparation of diaryl naphthyl methanes |
| 08/26/2003 | US6610702 Ammonium salts of inositol hexaphosphate, and uses thereof |
| 08/26/2003 | US6610660 O2-arylated or O2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and O2-substituted 1-[(2-carboxylato) pyrrolidin-1-yl] diazen-1-ium-1,2-diolates |
| 08/26/2003 | US6610284 Preparation for prevention and healing of inflammation affections |
| 08/21/2003 | WO2003069303A2 Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof |
| 08/21/2003 | WO2003068740A1 Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands |
| 08/21/2003 | WO2003068739A1 Method of manufacturing an amorphous form of the hemi-calcium salt of (3r, 5r) 7- 3-phenyl-4-phenylcarbamoyl-2-(4-fluorophenyl)-5-isopropyl-pyrrol-1-yl!-3, 5-dihydroxyheptanoic acid (atorvastatin) |
| 08/21/2003 | WO2003068738A1 Pyrrole derivatives as ligands of melanocortin receptors |
| 08/21/2003 | WO2003068212A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases |
| 08/21/2003 | WO2003067986A1 Δ1 pyrrolines and the use thereof in pest control |
| 08/21/2003 | WO2003018549A3 Bicyclic compounds as inhibitors of chemokine binding to us28 |
| 08/21/2003 | WO2003007930A3 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 08/21/2003 | WO2002062755A3 Polyamide analogs as dna minor groove binders |
| 08/21/2003 | WO2002046158A3 Piperidine/piperazine-type inhibitors of p38 kinase |
| 08/21/2003 | WO2002002512A3 Compounds to treat alzheimer's disease |
| 08/21/2003 | US20030158441 Methods of making intermediates from polyhydroxyalkanoates |
| 08/21/2003 | US20030158274 Hydrogenolyzing a polylactone to form a diol. |
| 08/21/2003 | US20030158252 Especially trypsin-like serine proteases, such as chymotrypsin, trypsin, thrombin, plasmin and factor Xa. |
| 08/21/2003 | US20030158225 Novel compounds |
| 08/21/2003 | US20030158186 Compositions and methods for treating heart failure |
| 08/21/2003 | US20030158185 Novel use of phenylheteroakylamine derivatives |
| 08/21/2003 | US20030158173 NK 1 antagonists |
| 08/21/2003 | CA2476446A1 Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases |
| 08/20/2003 | EP1335988A2 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds |
| 08/20/2003 | EP1335901A1 Pharmaceutically active sulfanilide derivatives |
| 08/20/2003 | EP1335898A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 08/20/2003 | EP1150944B1 N2-phenylamidine derivatives |
| 08/20/2003 | EP0831829B1 Heterocyclic ring-fused pyrimidine derivatives |
| 08/20/2003 | CN1437583A Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides |
| 08/20/2003 | CN1437578A (P-amino-hyaroxyphenyl)-acrylamide derivatives and dyes containing said compounds |
| 08/20/2003 | CN1437485A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 08/20/2003 | CN1437484A New formulation comprising a beta-blocker and optionally a cholesterol-lowering agent |
| 08/20/2003 | CN1437473A Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| 08/20/2003 | CN1118467C 1,3,8-triaza-spiro [4,5] decan-4-on derivatives |
| 08/19/2003 | US6608227 Benzylcycloalkyl amines as modulators of chemokine receptor activity |
| 08/19/2003 | US6608196 Structurally diverse; parallel approach |
| 08/19/2003 | US6608095 Sulfonylbenzene and sulfonamidobenzene compounds which inhibit COX-2; treatment of a medical condition in which prostaglandins are implicated as pathogens |
| 08/19/2003 | US6608093 Polyarylpyrazole or polyarylpyrole or polyaryltriazole compounds or intermediates for pesticides |
| 08/19/2003 | US6608061 Bisaryl compound and medicament for cancer treatment comprising the same |
| 08/19/2003 | US6608019 Alkoxy-substituted perfluorocompounds |
| 08/14/2003 | WO2003066889A2 Assay for acytyltransferase or deacetylase activity |
| 08/14/2003 | WO2003066579A2 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 08/14/2003 | WO2003066574A1 Aromatic amino acid derivatives and medicinal compositions |
| 08/14/2003 | WO2003066035A2 Compounds for inhibiting insulin secretion and methods related thereto |
| 08/14/2003 | US20030153788 Oxidizing an amino alcohol (obtained by ring opening the epoxy, aziding, reducing and reacting it with a carboxylic acid); stereoselectivity; protease inhibitors: antiallergens; anticarcinogenic and hypotensive agents |
| 08/14/2003 | US20030153611 Antitumor agents promoting the detachment of endothelial cells forming tumor, inhibiting tubulin polymerization |
| 08/14/2003 | US20030153596 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 08/14/2003 | US20030153577 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 08/14/2003 | US20030153559 Treatment of an oxygen and/or energy deficit; a poly(adenosine diphosphate ribose)-polymerase inhibitor; treating autoimmune, neurodegenerative and diseases caused by a toxic effect; viricides |
| 08/14/2003 | US20030153555 Novel compounds |
| 08/14/2003 | US20030153507 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 08/14/2003 | US20030153465 Substituted aryl ketones |
| 08/14/2003 | CA2473505A1 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 08/13/2003 | EP1335250A1 Electrophotographic organophotoreceptors with novel charge transport materials |
| 08/13/2003 | EP1334961A1 Process for the preparation of glycine-N,N-diacetic acid derivatives |
| 08/13/2003 | EP1334097A2 Process for the preparation of ligands for olefin polymerization catalysts |
| 08/13/2003 | EP1334085A1 Sulfamides as gamma-secretase inhibitors |
| 08/13/2003 | EP1334084A2 Phosgene-free process for preparing carbamates |
| 08/13/2003 | EP1334083A2 1,4-disubstituted benzenes as insecticides |
| 08/13/2003 | EP1222166B1 Novel p-aminophenols and colorants containing said compounds |
| 08/13/2003 | EP1019411A4 Process for synthesizing carbapenem side chain intermediates |
| 08/13/2003 | EP0470128B2 Active carbonates of polyalkylene oxides for modification of polypeptides |
| 08/12/2003 | US6605729 Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) |
| 08/12/2003 | US6605728 Starting from atorvastatin lactone, where continuous agitation at a very low speed provides optimum drying conditions for avoiding clod formation and particle attrition |
| 08/12/2003 | US6605677 Olefin polymerization processes using supported catalysts |
| 08/12/2003 | US6605636 Atorvastatin hemi-calcium form VII |
| 08/12/2003 | US6605632 Affinity for melatonin receptors |